Plus Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
PSTV Nasdaq 2836 plustherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Plus Therapeutics, Inc.

Plus Therapeutics Reports ReSPECT-GBM Clinical Trial Update at the 2024 Congress of Neurological Surgeons Annual Meeting - Oct 1st, 2024 11:30 am
Plus Therapeutics Showcases New Interim ReSPECT-GBM Phase 2 Trial Data at the 2024 Congress of Neurological Surgeons Annual Meeting - Sep 18th, 2024 11:30 am
Plus Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Sep 4th, 2024 11:30 am
Plus Therapeutics Second Quarter 2024 Earnings: Beats Expectations - Aug 17th, 2024 1:48 pm
Q2 2024 Plus Therapeutics Inc Earnings Call - Aug 15th, 2024 1:42 pm
Plus Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights - Aug 14th, 2024 8:16 pm
Plus Therapeutics Presents Positive Clinical Trial Results at the 2024 SNO/ASCO CNS Metastases Conference - Aug 13th, 2024 11:30 am
Plus Therapeutics Presents Positive Interim ReSPECT-LM Phase 1 Data for Leptomeningeal Metastases at 2024 SNO/ASCO CNS Metastases Conference - Aug 12th, 2024 11:30 am
Plus Therapeutics to Announce Second Quarter Financial Results and Host Conference Call on August 14, 2024 - Aug 8th, 2024 11:30 am
Plus Therapeutics Showcases Leptomeningeal Metastases Programs at 2024 SNO/ASCO Conference - Jul 25th, 2024 11:30 am
Plus Therapeutics to Present at the Gordon Research Conference Radionuclide Theranostics for the Management of Cancer - Jul 2nd, 2024 11:30 am
Plus Therapeutics Expands Management Team and Reports $3.3M Advance Payment from CPRIT - Jun 7th, 2024 11:30 am
Plus Therapeutics Announces New Employment Inducement Grants - May 17th, 2024 9:00 pm
Plus Therapeutics Inc (PSTV) Q1 2024 Earnings Call Transcript Highlights: Strategic Progress ... - May 16th, 2024 7:05 am
Plus Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights - May 15th, 2024 8:15 pm
Plus Therapeutics to Announce First Quarter Financial Results and Host Conference Call on May 15, 2024 - May 13th, 2024 11:30 am
Plus Therapeutics Provides Highlights Regarding Leptomeningeal Metastases Acquisition and Topline Clinical Trial Data on the FORESEE Trial - May 9th, 2024 3:29 pm
Plus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical Trial Data from the FORESEE Trial - May 8th, 2024 9:35 pm
Plus Therapeutics Announces Private Placement Financing of up to $18 Million - May 6th, 2024 11:30 am
Micro-Cap Brain Cancer Focused Plus Therapeutics Poised To Receive $3M From US Department of Defense - Apr 22nd, 2024 1:00 pm